Zobrazeno 1 - 6
of 6
pro vyhledávání: '"MaryAnn Morgan-Cox"'
Autor:
Andrew Blauvelt, Jacob P Thyssen, Emma Guttman-Yassky, Thomas Bieber, Esther Serra-Baldrich, Eric Simpson, David Rosmarin, Hany Elmaraghy, Eric Meskimen, Chitra R Natalie, Zhuqing Liu, Chenjia Xu, Evangeline Pierce, MaryAnn Morgan-Cox, Esther Garcia Gil, Jonathan I Silverberg
Publikováno v:
British Journal of Dermatology. 188:740-748
Background Lebrikizumab is a novel, high-affinity monoclonal antibody that selectively binds to interleukin (IL)-13. Objectives To evaluate the efficacy and safety of lebrikizumab monotherapy in adolescent and adult patients with moderate-to-severe a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f4d36b44a1aafe190632d8a5deca085
https://doi.org/10.1093/bjd/ljad022
https://doi.org/10.1093/bjd/ljad022
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
Autor:
Michael Durante, Jochen Schmitz, Stuart Friedrich, Elina Berliba, Jay Tuttle, Toshifumi Hibi, Bal R. Bhandari, Janelle Laskowski, Marc Ferrante, William J. Sandborn, MaryAnn Morgan-Cox, Geert R. D'Haens, Brian G. Feagan, Paul Klekotka
Publikováno v:
Gastroenterology, 158(3), 537-549.e10. W.B. Saunders Ltd
BACKGROUND & AIMS: Interleukin 23 contributes to the pathogenesis of ulcerative colitis (UC). We investigated the effects of mirikizumab, a monoclonal antibody against the p19 subunit of interleukin 23, in a phase 2 study of patients with UC. METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a62eed3231d132fa474bb9f7b87db6
https://lirias.kuleuven.be/handle/123456789/641700
https://lirias.kuleuven.be/handle/123456789/641700
Autor:
Alan Menter, Kim Papp, C. Leonardi, Dipak R. Patel, Robert Bissonnette, MaryAnn Morgan-Cox, Catherine Maari, Jay Tuttle, Amaf investigators, Kristian Reich, Atsuyuki Igarashi, J Li, Paul Klekotka, Emily Edson-Heredia, Phoebe Rich, Stuart Friedrich
Publikováno v:
The British journal of dermatology. 181(1)
BACKGROUND Inhibiting interleukin (IL)-23 in patients with psoriasis has demonstrated high levels of skin clearance. OBJECTIVES To investigate, in a phase II (AMAF; NCT02899988), multicentre, double-blind trial, the efficacy and safety of three doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc8693a4d3e0faed648b9a48d542a22f
https://pubmed.ncbi.nlm.nih.gov/30734266
https://pubmed.ncbi.nlm.nih.gov/30734266
Autor:
Fumihito Hirai, Jay Tuttle, Elisa Gomez Valderas, Toshifumi Hibi, Debra L. Miller, Peter D.R. Higgins, William J. Sandborn, Bruce E. Sands, April N. Naegeli, Laurent Peyrin-Biroulet, MaryAnn Morgan-Cox, Paul F. Pollack, Ruth Belin
Publikováno v:
Gastroenterology. 156:S-216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b30f2aac4fb3ac32ef8916fe30ffdce3
https://doi.org/10.1016/s0016-5085(19)37335-4
https://doi.org/10.1016/s0016-5085(19)37335-4
Publikováno v:
Southern medical journal. 103(12)
The problem of high body mass index (BMI) for age in the Head Start population in Texas is of great concern. The primarily Mexican American population is at high risk for diabetes and cardiovascular disease. This study examines the prevalence of elev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c86b375390ac9b97f9652064d7a936
https://pubmed.ncbi.nlm.nih.gov/20978460
https://pubmed.ncbi.nlm.nih.gov/20978460
Autor:
Catherine J. McNeal, John P. Erwin, Juhee Song, Joji J. Varghese, Dean Kjar, Mazi Mahjoobi, MaryAnn Morgan-Cox
Publikováno v:
Journal of the American College of Cardiology. 55:A57.E544
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e390039b2e5274751be797f7fde57f08
https://doi.org/10.1016/s0735-1097(10)60545-1
https://doi.org/10.1016/s0735-1097(10)60545-1